Skip to main content
Account

Table 1 NPs played their biologic role by inducing ROS burst in cells

From: Reactive Oxygen Species-Related Nanoparticle Toxicity in the Biomedical Field

No.

Type of NPs

Potential applications

ROS

Dose

Molecule mechanism of biotoxicity

References

1

Nano-C60

Antibacterial agents, Anticancer agents.

1 μg/mL

Necrosis, apoptosis, autophagy, DNA fragmentation, cell membrane damage.

[26,27,28]

2

Carbon-based nanodots

Antibacterial agents.

> 1 mg/mL

Oxidize the phospholipids, destroy the membranes.

[29]

3

Ag

Antibacterial agents.

150 μg/mL

Intracellular oxidation, membrane potential variation, membrane permeability disruption, DNA damage, genomic instability, cell cycle arrest, cellular contents release, inactivate proteins, autophagy, disturb electron transfer process.

[30,31,32,33,34,35,36]

4

Gold-silver nanocage

Antibacterial agents.

2.5 μg/mL

Destruction of cell membrane, apoptosis.

[37]

5

ZnO

Wastewater purification, antibacterial agents, antitumor agents, fillers in orthopedic, and dental implants.

20 μg/mL

Disintegration the cell membrane, inhibition enzyme activity, inhibition DNA synthesis, DNA damage, interruption of energy transduction, mitochondrial damage, apoptosis, intracellular outflow, mitotic arrest, carcinogenic.

[38,39,40,41,42,43,44,45]

6

Gold

Anticancer agents, antibacterial agents.

20 μM

Collapse membrane potential, inhibit ATPase activities, inhibit the subunit of ribosome.

[46, 47]

7

MgO

Antibacterial agents, anticancer agents.

100 mg/mL

Lipid peroxidation, apoptosis.

[48, 49]

8

Fe3O4

Antibacterial agents.

32 μg/mL

DNA cleavage.

[50]

9

CdSe

Antibacterial agents.

 

Inhibition proliferation.

[51]

10

TiO2

Antimicrobial agents, air and water purification, dental prosthesis.

10 μg/mL

Loss respiratory activity, interfere oxidative phosphorylation, DNA lesions, mitochondrial dysfunction, carcinogenicity.

[52,53,54,55,56,57]

11

Al2O3

Antibacterial agents, cross-linker.

0.16 mg/L

DNA damage, mutagenesis.

[58, 59]

12

VO2

Antimicrobial agents.

2.5 μg/mL

Mitochondrial dysfunction apoptosis.

[60, 61]

13

V2O5

Antimicrobial agents.

20 mg/L

Interruption mitochondrial function.

[62, 63]

14

PCAE

Antimicrobial agents.

30 μg/mL

Membrane damages.

[64]

15

Co-ZnO

Antimicrobial agents.

20 μg/mL

Low toxicity.

[65]

16

Hybrid Gold/Polymer

Antimicrobial agents.

Unknown

Unknown

No cytotoxicity.

[66]

17

Ag-Fe NPs

Antimicrobial agents.

100 mg/L

LDH release, disruption membrane integrity.

[67]

18

Phycocyanin-ZnO nanorod

Protect cell.

50 μg/mL

Decrease in ROS production.

[68]

19

Ag/lyz-Mt

Antimicrobial agents, water disinfection.

160 μg/mL

Damage cell membrane.

[69]

20

PEGylated ZnO

Antimicrobial agents, biological labeling.

45 ppm

Low cytotoxicity.

[70]

21

CdS NPs

Antimicrobial agents.

4 μg/mL

Inhibition proper cell septum formation, change morphology, fragment nuclei.

[71]

22

CdTe

Antimicrobial agents.

0.4 mg/L

Morphological damages, apoptosis, genotoxicity.

[72]

23

ZnO@APTMS/Cu QDs

Antibacterial agents.

1.4 × 10-4 M

Inhibition proliferation.

[73]

24

CuO

Antimicrobial agents.

5 mg/L

Increase cell permeability, lipid peroxidation, DNA damage, morphological alterations, mitochondrial dysfunction, interruption ATP synthesis.

[74,75,76]

25

Mn3O4

Antioxidant.

20 ng/μL

Protect biomolecules against ROS.

[77]

26

PEGylated nanoceria

Antioxidant.

10 μM

Cell protection, radical scavenger.

[78]

27

CeO2

Against oxidative damage.

2.5 μg/mL

Suppressed ROS production, protect cells, and tissues.

[79]

28

AuNPs-rGO-NC

Anticancer agents, antimicrobial agents.

50 μg/mL

Reduction cell activity,

[80]

29

CONPs

Anticancer agents.

10 μM

DNA damage.

[81]

30

Graphene

Cancer theotherapy, bioimaging, biosensing.

25 μg/mL

DNA damage, mutagenesis.

[82, 83]

31

Fe2O3

Antibacterial agents.

80 μg/mL

DNA damage.

[84]

32

NiO

Antibacterial agents.

10 mg/L

DNA damage.

[85, 86]

33

PtAuNRs

Anticancer agents.

OD at 0.5

Induce hyperthermia.

[87]

34

SWCNTs

Clinical diagnostic agent, bioengineered research.

50 μg/cm2

DNA damage.

[88]

35

bsCdS

Anticancer agents.

15 μg/mL

Apoptosis, depletion ATP, DNA damage.

[89]

36

Ag@OTV

Against H1N1 infection.

Unknown

Less cytotoxicity.

[90]

37

PATA3-C4@CuS

Antibacterial agents.

5.5 μg/mL

Less cytotoxicity.

[91]

Navigation